Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Checkmate Pharmaceuticals Inc
(NQ:
CMPI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 27, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
10.48 (51)
Ask (Size)
10.50 (12)
Prev. Close
10.50
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
22,038,218
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI
May 17, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI
May 05, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
More News
Read More
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022
April 20, 2022
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge
April 19, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 19, 2022
Via
Benzinga
54 Biggest Movers From Yesterday
April 20, 2022
Via
Benzinga
Why Is Arqit Quantum (ARQQ) Stock Down Today?
April 19, 2022
Via
InvestorPlace
Dow Up Over 400 Points as Wall Street Pores Over Earnings
April 19, 2022
Via
Talk Markets
Why Is Checkmate Pharmaceuticals (CMPI) Stock Up 300% Today?
April 19, 2022
Via
InvestorPlace
Mid-Day Market Update: Crud Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher
April 19, 2022
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
April 19, 2022
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points
April 19, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 19, 2022
Via
Benzinga
The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu
April 19, 2022
Via
Benzinga
Checkmate Pharma Shares Skyrocket Over 300% On Regeneron $250M Acquisition Deal
April 19, 2022
Via
Benzinga
Why Checkmate Pharmaceuticals Shares Are Skyrocketing
April 19, 2022
Via
Benzinga
CMPI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Checkmate Pharmaceuticals, Inc. Is Fair to Shareholders
April 19, 2022
From
Halper Sadeh LLP
Via
Business Wire
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
April 12, 2022
Via
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Via
Benzinga
60 Biggest Movers From Yesterday
February 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 15, 2021
Via
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Via
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Via
Benzinga
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.